DK1664050T3 - Neuroprotective bicyclic compounds and pharmaceutical compositions containing them - Google Patents
Neuroprotective bicyclic compounds and pharmaceutical compositions containing them Download PDFInfo
- Publication number
- DK1664050T3 DK1664050T3 DK04782733.2T DK04782733T DK1664050T3 DK 1664050 T3 DK1664050 T3 DK 1664050T3 DK 04782733 T DK04782733 T DK 04782733T DK 1664050 T3 DK1664050 T3 DK 1664050T3
- Authority
- DK
- Denmark
- Prior art keywords
- substituted
- aryl
- heteroalkyl
- alkyl
- alkenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49995603P | 2003-09-03 | 2003-09-03 | |
| PCT/US2004/028308 WO2005023815A2 (en) | 2003-09-03 | 2004-08-31 | Neuroprotective bicyclic compounds and methods for their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1664050T3 true DK1664050T3 (en) | 2016-03-07 |
Family
ID=34272894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04782733.2T DK1664050T3 (en) | 2003-09-03 | 2004-08-31 | Neuroprotective bicyclic compounds and pharmaceutical compositions containing them |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8067425B2 (enExample) |
| EP (1) | EP1664050B1 (enExample) |
| JP (1) | JP4842817B2 (enExample) |
| DK (1) | DK1664050T3 (enExample) |
| ES (1) | ES2564803T3 (enExample) |
| HU (1) | HUE028528T2 (enExample) |
| PL (1) | PL1664050T3 (enExample) |
| SI (1) | SI1664050T1 (enExample) |
| WO (1) | WO2005023815A2 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1311269T3 (da) * | 2000-08-04 | 2012-03-26 | Dmi Biosciences Inc | Fremgangsmåde til anvendelse af diketopiperaziner og sammensætning, som indeholder dem |
| EP1648873A4 (en) * | 2003-03-20 | 2008-06-25 | Neuren Pharmaceuticals Ltd | NEUROPROTECTIVE MACROCYLIC COMPOUNDS AND METHODS OF THEIR APPLICATION |
| ES2572975T3 (es) | 2003-05-15 | 2016-06-03 | Ampio Pharmaceuticals, Inc. | Tratamiento de enfermedades mediadas por los linfocitos T |
| WO2008063311A2 (en) * | 2006-10-11 | 2008-05-29 | Neuren Pharmaceuticals Limited | Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals |
| US8519127B2 (en) * | 2003-09-03 | 2013-08-27 | Mike John Bickerdike | Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy |
| US8791117B2 (en) * | 2003-09-03 | 2014-07-29 | Neuren Pharmaceuticals Limited | Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals |
| JP5856843B2 (ja) * | 2008-05-27 | 2016-02-10 | アンピオ ファーマシューティカルズ，インコーポレイテッド | ジケトピペラジンを用いた医薬組成物 |
| US9891219B2 (en) * | 2008-10-10 | 2018-02-13 | Mayo Foundation For Medical Education And Research | Methods for treating neuromyelitis optica (NMO) by administration of eculizumab to an individual that is aquaporin-4 (AQP4)-IgG autoantibody positive |
| US7928233B2 (en) * | 2009-02-10 | 2011-04-19 | Hoffmann-La Roche Inc. | Spiroindolinone pyridine derivatives |
| EP2613786A4 (en) | 2010-09-07 | 2013-10-23 | Dmi Acquisition Corp | TREATMENT OF DISEASES |
| US9925300B2 (en) | 2011-10-10 | 2018-03-27 | Ampio Pharmaceuticals, Inc. | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
| PH12014500685B1 (en) | 2011-10-10 | 2018-10-03 | Ampio Pharmaceuticals Inc | Treatment of degenerative joint disease |
| JP6231484B2 (ja) | 2011-10-28 | 2017-11-15 | アンピオ ファーマシューティカルズ，インコーポレイテッド | 鼻炎の処置 |
| EP2909214B1 (en) * | 2012-10-22 | 2020-07-22 | City of Hope | Etp derivatives |
| CN105101965B (zh) | 2013-03-15 | 2021-03-09 | 安皮奥制药股份有限公司 | 用于干细胞活动化、归巢、扩增和分化的组合物及其使用方法 |
| EP3024463B1 (en) | 2013-07-25 | 2020-03-25 | Neuren Pharmaceuticals Limited | Neuroprotective bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders |
| JP6723222B2 (ja) | 2014-08-18 | 2020-07-15 | アンピオ ファーマシューティカルズ，インコーポレイテッド | 関節病態の治療 |
| US11389512B2 (en) | 2015-06-22 | 2022-07-19 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
| SG11201811368SA (en) | 2016-05-26 | 2019-01-30 | Amino Up Chemical Co Ltd | Sleep improving agent |
| WO2018053345A1 (en) | 2016-09-15 | 2018-03-22 | City Of Hope | Dithio etp derivatives |
| US11590141B2 (en) | 2018-03-16 | 2023-02-28 | Scent Science International Inc. | Prophylactic or therapeutic agent for hypoxic injury, ischemia-reperfusion injury and inflammation, cell protection agent for transplantation, and bio-preservation agent |
| US11090303B2 (en) | 2018-05-15 | 2021-08-17 | Lloyd Hung Loi Tran | Therapeutic agent composition and method of use, for treatment of mild congnitive impairment, depression, and psychological disorders |
| US12472177B2 (en) | 2019-10-22 | 2025-11-18 | Neuren Pharmaceuticals Limited | Bicyclic compounds and methods for their use in treating Pitt Hopkins syndrome |
| GEAP202316350A (en) * | 2021-02-12 | 2023-10-25 | Neuren Pharmaceuticals Ltd | Treatments of prader-willi syndrome |
| BE1032058B1 (nl) * | 2023-10-26 | 2025-10-02 | Rousselot Bv | Cyclische analoog van glycine-proline voor gebruik bij de preventie en/of behandeling van fibrose |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH469006A (de) * | 1965-07-07 | 1969-02-28 | Sandoz Ag | Verfahren zur Herstellung neuer synthetischer Alkaloide |
| EP0626174A3 (en) * | 1993-04-21 | 1996-01-03 | Takeda Chemical Industries Ltd | Method and composition for the prophylaxis and / or treatment of underactive organs. |
| US7202279B1 (en) | 1998-02-11 | 2007-04-10 | Georgetown University | Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| WO2003039487A2 (en) * | 2001-11-09 | 2003-05-15 | Neuronz Limited | Cyclo(prolyl-glycine) and methods of use to treat neural disorders |
| WO2003041655A2 (en) | 2001-11-13 | 2003-05-22 | Loi Tran | Therapeutic agent composition and method of use |
| US7232798B2 (en) * | 2001-11-13 | 2007-06-19 | Tran Loi H | Neuroprotection and neuroegenisis by administering cyclic prolyl glycine |
| EP1648873A4 (en) * | 2003-03-20 | 2008-06-25 | Neuren Pharmaceuticals Ltd | NEUROPROTECTIVE MACROCYLIC COMPOUNDS AND METHODS OF THEIR APPLICATION |
-
2004
- 2004-08-31 HU HUE04782733A patent/HUE028528T2/en unknown
- 2004-08-31 DK DK04782733.2T patent/DK1664050T3/en active
- 2004-08-31 PL PL04782733T patent/PL1664050T3/pl unknown
- 2004-08-31 SI SI200432303T patent/SI1664050T1/sl unknown
- 2004-08-31 WO PCT/US2004/028308 patent/WO2005023815A2/en not_active Ceased
- 2004-08-31 EP EP04782733.2A patent/EP1664050B1/en not_active Expired - Lifetime
- 2004-08-31 ES ES04782733.2T patent/ES2564803T3/es not_active Expired - Lifetime
- 2004-08-31 JP JP2006525396A patent/JP4842817B2/ja not_active Expired - Lifetime
- 2004-08-31 US US10/570,395 patent/US8067425B2/en not_active Expired - Lifetime
-
2006
- 2006-04-07 US US11/399,974 patent/US7776876B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP4842817B2 (ja) | 2011-12-21 |
| EP1664050B1 (en) | 2015-12-09 |
| WO2005023815A2 (en) | 2005-03-17 |
| JP2007504235A (ja) | 2007-03-01 |
| EP1664050A2 (en) | 2006-06-07 |
| US20070197511A1 (en) | 2007-08-23 |
| HUE028528T2 (en) | 2016-12-28 |
| US8067425B2 (en) | 2011-11-29 |
| SI1664050T1 (sl) | 2016-04-29 |
| US7776876B2 (en) | 2010-08-17 |
| US20060258663A1 (en) | 2006-11-16 |
| ES2564803T3 (es) | 2016-03-29 |
| WO2005023815A3 (en) | 2005-07-21 |
| PL1664050T3 (pl) | 2016-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1664050T3 (en) | Neuroprotective bicyclic compounds and pharmaceutical compositions containing them | |
| CA2790070C (en) | Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors | |
| US8013170B2 (en) | Substituted pyrrolo[1,2-d][1,4]-diazonines and treatment of brain damage | |
| CN102159578B (zh) | 四氢咪唑并[1,5-a]吡嗪衍生物的盐,其制备方法及其在医药上的应用 | |
| AU2867899A (en) | Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders | |
| US7863304B2 (en) | Analogs of glycyl-prolyl-glutamate | |
| US9119851B2 (en) | Cyclic Glycyl-2-Allyl Proline improves cognitive performance in impaired animals | |
| EP1888618A2 (en) | Analogs of glycyl-prolyl-glutamate | |
| US20250367192A1 (en) | Bicyclic compounds and methods for their use in treating pitt hopkins syndrome | |
| US8519127B2 (en) | Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy | |
| US20090263334A1 (en) | Cyclic Glycyl-2-Allyl Proline Improves Cognitive Performance in Impaired Animals | |
| US6747042B2 (en) | N-heterocyclic derivatives |